Ganciclovir Withdrawn Phase 1 Trials for Encephalopathies / Radiculitis / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00000856A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.